Nonsurgical treatment of benign prostatic hypertrophy
β Scribed by P. Ekman
- Publisher
- Springer-Verlag
- Year
- 1989
- Tongue
- English
- Weight
- 719 KB
- Volume
- 6
- Category
- Article
- ISSN
- 0724-4983
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Background. Epidemiologic studies in castrates strongly support the key role of the testis in the pathogenesis of benign prostatic hyperplasia (BPH). Since the testis secretes both androgen and estrogen, both of these hormones have been implicated in BPH. Many data support the important role of dihy
The concentrations of immunoglobulins (IgG, IgA and IgM) have been determined in tissues of human benign prostatic hypertrophy by means of different immunological techniques. Results obtained show that IgA is quantitatively the most important immunoglobulin in prostatic tissue. Treatment with anti-a
Many techniques have been used to relieve obstructive symptoms associated with benign prostatic hypertrophy. Transurethral resection of the prostate (TURP) with an electrocautery loop is the most commonly performed operation to relieve bladder neck and urethral obstruction caused by prostatic adenom